Capital International, Inc. Galapagos Nv Transaction History

Capital International, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$51.32 - $68.5 $546,711 - $729,730	-10,653 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$47.03 - $57.12 $787,282 - $956,188	-16,740 Reduced 61.11%	10,653 $587,000
Q2 2021 Aug 16, 2021	BUY	$68.86 - $83.34 $492,142 - $595,630	7,147 Added 35.3%	27,393 $1.89 Million
Q1 2021 May 14, 2021	SELL	$76.15 - $111.94 $49,269 - $72,425	-647 Reduced 3.1%	20,246 $1.56 Million
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $2.02 Million - $3.1 Million	20,893 New	20,893 $2.07 Million

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.76B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.